Outcomes on the pharmacopsychometric triangle in bupropion‐SR vs. buspirone augmentation of citalopram in the STAR* D trial
P Bech, M Fava, MH Trivedi… - Acta Psychiatrica …, 2012 - Wiley Online Library
… With regard to the second aspect of the triangle – side effects – our … of buspirone augmentation
(20.6%) than augmentation with bupropion-SR (12.5%) because of intolerable side effects…
(20.6%) than augmentation with bupropion-SR (12.5%) because of intolerable side effects…
STAR* D: what have we learned?
AJ Rush - American Journal of Psychiatry, 2007 - Am Psychiatric Assoc
… to sertraline) or an out-of-class switch (eg, citalopram to bupropion-SR) is effective, as was
a … While bupropion-SR and buspirone were not different as augmentation options in the …
a … While bupropion-SR and buspirone were not different as augmentation options in the …
Clinical implications of the STAR* D trial
A John Rush, S Jain - Antidepressants: From Biogenic Amines to New …, 2019 - Springer
… citalopram might decline switching but accept augmentation … of treatment with buspirone
(20.6%) than bupropion-SR (12.5… (either citalopram combined with bupropion-SR or buspirone …
(20.6%) than bupropion-SR (12.5… (either citalopram combined with bupropion-SR or buspirone …
Bupropion: a systematic review and meta-analysis of effectiveness as an antidepressant
…, I Angelescu, D Baumeister… - Therapeutic …, 2016 - journals.sagepub.com
… in citalopram and bupropion and citalopram and buspirone … no statistical differences between
bupropion SR and placebo on … ’ in comparing bupropion with buspirone augmentation. …
bupropion SR and placebo on … ’ in comparing bupropion with buspirone augmentation. …
[HTML][HTML] Treatment of schizophrenia evaluated via the pharmacopsychometric triangle—An integrative approach with emphasis on well-being and functioning
P Kølbæk, O Mors, CU Correll, SD Østergaard - Schizophrenia, 2023 - nature.com
… (SR) and buspirone augmentation of citalopram, finding that bupropion-SR was superior in
… However, this study was based on re-analysis of data from a placebo-controlled clinical trial …
… However, this study was based on re-analysis of data from a placebo-controlled clinical trial …
Serotonergic drugs for depression and beyond
…, S Cartwright, D Ann Morrissette - Current drug …, 2013 - ingentaconnect.com
… Finally, citalopram, a racemic mixture, has mild antihistamine properties that are not …
Buspirone was an augmentation agent in level 2 of the STAR*D trial, along with bupropion aug…
Buspirone was an augmentation agent in level 2 of the STAR*D trial, along with bupropion aug…
Antidepressant combinations: cutting edge psychopharmacology or passing fad?
ME Thase - Current psychiatry reports, 2013 - Springer
… strategies (eg, augmentation of the antidepressant with lithium … In STAR*D, the combination
of citalopram and bupropion SR … combination of citalopram and the anxiolytic buspirone, not …
of citalopram and bupropion SR … combination of citalopram and the anxiolytic buspirone, not …
Rational Polypharmacy in the Acute Therapy of Major Depression
P Bech, C Csillag - Effects of Antidepressants, 2012 - books.google.com
… After failure to respond to monotherapy with the SSRI citalopram, patients went on to …
augmentation with bupropion-SR (sustained release) or buspirone in a controlled, doubleblind trial. …
augmentation with bupropion-SR (sustained release) or buspirone in a controlled, doubleblind trial. …
The VA augmentation and switching treatments for improving depression outcomes (VAST-D) study: Rationale and design considerations
S Mohamed, GR Johnson, JE Vertrees, PD Guarino… - Psychiatry …, 2015 - Elsevier
… a trial of three “next-step” strategies: switching to another antidepressant (bupropion-SR) or
augmenting the current antidepressant with either another antidepressant (bupropion-SR) or …
augmenting the current antidepressant with either another antidepressant (bupropion-SR) or …
Pharmacotherapy of major depression in late life: what is the role of new agents?
K Patel, PS Abdool, TK Rajji… - Expert Opinion on …, 2017 - Taylor & Francis
… a warning about the potential of citalopram to induce an increase … use of atypical antipsychotic
as augmenting agents in non-… to a combination of an SSRI and buspirone, which has been …
as augmenting agents in non-… to a combination of an SSRI and buspirone, which has been …